有投资者向新华制药提问, 从国家药品监督管理局药品审评中心的药品受理评审的公告看,公司从24年12月份至今已经有5、6款药已经过审了(含补充申请),但是近一个月来公司一反之前的常态,不再公布,不知是为了什么原因?之前几乎每个月都会及时公布过审的药品情况。公司回答表示,感谢您对公司关心与支持。2024年12月2日、3日及2025年1月10日公司收到有关药品批复即刊发了有关公告,后续收到批复亦会根据...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.